NEW YORK (GenomeWeb) – Luminex today announced it has signed a distribution and supply agreement with Bio-Techne that will last through 2020.

Under the terms of the agreement, Bio-Techne will distribute Luminex instruments, including the Luminex 200, Flexmap 3D, and Magpix, in major markets worldwide. Bio-Techne will also continue to develop and commercialize immunoassays for the Luminex platform.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.

An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.

In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.

Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.